Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

Publication | Open Access

DOI Full Paper Access

237

Citations

References

2017

Year

Sandra M. Swain, Michael S. Ewer, Giuseppe Viale, Suzette Delaloge, Jean-Marc Ferrero, Mark Verrill, Rámón Colomer, Cláudia Vieira, Theresa L. Werner, Hannah Douthwaite,

Annals of Oncology